Document is current
Any future updates will be listed below
-
Authors
Kusejko, Katharina
Chammartin, Frédérique
Smith, Daniel
Odermatt, Marc
Schuhmacher, Julian
Koller, Michael
Günthard, Huldrych F.
Briel, Matthias
Bucher, Heiner C.
Speich, Benjamin
,
Abela, I.
Aebi-Popp, K.
Anagnostopoulos, A.
Battegay, M.
Bernasconi, E.
Braun, D. L.
Bucher, H. C.
Calmy, A.
Cavassini, M.
Ciuffi, A.
Dollenmaier, G.
Egger, M.
Elzi, L.
Fehr, J.
Fellay, J.
Furrer, H.
Fux, C. A.
Günthard, H. F.
Hachfeld, A.
Haerry, D.
Hasse, B.
Hirsch, H. H.
Hoffmann, M.
Hösli, I.
Huber, M.
Kahlert, C. R.
Kaiser, L.
Keiser, O.
Klimkait, T.
Kouyos, R. D.
Kovari, H.
Kusejko, K.
Martinetti, G.
Martinez de Tejada, B
Marzolini, C.
Metzner, K. J.
Müller, N.
Nemeth, J.
Nicca, D.
Paioni, P.
Pantaleo, G.
Perreau, M.
Rauch, A.
Schmid, P.
Speck, R.
Stöckle, M.
Tarr, P.
Trkola, A.
Wandeler, G.
Yerly, S.
,
Amico, Patrizia
Aubert, John-David
Banz, Vanessa
Beckmann, Sonja
Beldi, Guido
Berger, Christoph
Berishvili, Ekaterine
Berzigotti, Annalisa
Binet, Isabelle
Bochud, Pierre-Yves
Branca, Sanda
Bucher, Heiner
Catana, Emmanuelle
Cairoli, Anne
Chalandon, Yves
De Geest, Sabina
De Rougemont, Olivier
De Seigneux, Sophie
Dickenmann, Michael
Dreifuss, Joëlle Lynn
Duchosal, Michel
Fehr, Thomas
Ferrari-Lacraz, Sylvie
Garzoni, Christian
Golshayan, Déla
Goossens, Nicolas
Halter, Fadi Haidar Jörg
Heim, Dominik
Hess, Christoph
Hillinger, Sven
Hirsch, Hans H.
Hirt, Patricia
Hofbauer, Günther
Huynh-Do, Uyen
Immer, Franz
Koller, Michael
Laager, Mirjam
Laesser, Bettina
Lamoth, Frédéric
Lehmann, Roger
Leichtle, Alexander
Manuel, Oriol
Marti, Hans-Peter
Martinelli, Michele
McLin, Valérie
Mellac, Katell
Merçay, Aurélia
Mettler, Karin
Müller, Antonia
Mueller, Nicolas J.
Müller-Arndt, Ulrike
Müllhaupt, Beat
Nägeli, Mirjam
Oldani, Graziano
Pascual, Manuel
Passweg, Jakob
Pazeller, Rosemarie
Posfay-Barbe, Klara
Rick, Juliane
Rosselet, Anne
Rossi, Simona
Rothlin, Silvia
Ruschitzka, Frank
Schachtner, Thomas
Schanz, Urs
Schaub, Stefan
Scherrer, Alexandra
Schnyder, Aurelia
Schuurmans, Macé
Schwab, Simon
Sengstag, Thierry
Simonetta, Federico
Stampf, Susanne
Steiger, Jürg
Stirnimann, Guido
Stürzinger, Ueli
Van Delden, Christian
Venetz, Jean-Pierre
Villard, Jean
Vionnet, Julien
Wick, Madeleine
Wilhelm, Markus
Yerly, Patrick
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31CA30_196245, 33CS30_177499/201369, 33CS30_177522/201385)
- License Information
-
More Information
Article History
Received: 29 November 2021
Accepted: 5 July 2022
First Online: 28 July 2022
Declarations
:
: The Corona VaccinE tRial pLatform (COVERALL) was approved by the research ethical committee Nordwest- and Zentralschweiz (BASEC Nr. 2021-00593), details can be found on the trial registration page (). All methods were carried out in accordance to Good Clinical Practice and the Declaration of Helsinki.
: Not applicable.
: KK, DS, JS, MO, MK, MB, BS and FC have no conflicts of interest. HCB has received in the 36 months prior to the submission of this manuscript grants, support for travelling, consultancy fees and honorarium from Gilead, BMS, Viiv Healthcare, Roche and Pfizer that were not related to this project. He serves as the president of the association contre le HIV et autres infections transmissibles. In this function, he has received support for the Swiss HIV Cohort Study from ViiV Healthcare, Gilead, BMS, and MSD. HFG, outside of this study, reports grants from the Swiss National Science Foundation, National Institutes of Health (NIH), and the Swiss HIV Cohort Study, unrestricted research grants from Gilead Sciences, Roche, and Yvonne Jacob Foundation, personal fees from consulting or advisory boards or data safety monitoring boards for Merck, Gilead Sciences, ViiV Healthcare, Mepha, and Sandoz. HFG’s institution received money for participation in the following clinical Covid-19 studies: 540-7773/5774 (Gilead), TICO (ACTIV-3, INSIGHT/NIH), and the Morningsky 435 study (Roche).
